On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...
Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
Peloton Interactive shares jumped Thursday after the exercise equipment maker's second-quarter revenue and adjusted earnings forecast topped analyst estimates.
You can view and print your statement by logging into your Social Security account: Go to the Social Security Administration ...
It’s that time of year again: time to gather the documents you need for filing your federal income taxes if you haven’t ...